GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, CDC25B, CSNK2A1, CXCL8, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F2, F3, FABP3, FLT3, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
14.7799 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F2, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
13.8378 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F2, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
13.8378 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.946 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.0567 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, CYP1B1, DRD2, EGFR, F10, F2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MIF, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
11.1521 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
11.1112 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MIF, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
11.1112 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, FABP3, FUT7, HSPA1A, HTR2B, MIF, PDE5A, PIM1, PPARA, PTGS1, PTGS2, XDH |
11.0476 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
10.9055 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F2, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
10.8122 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F2, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
10.6359 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, CA3, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, HTR5A, IGF1R, INSR, MAOB, MMP2, MMP9, PPARA, PTGS2, RORC, SRC, TEK |
10.3158 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR7, INSR, KDR, MAOB, MET, MIF, PPARA, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
10.3018 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALPL, APP, AXL, CA2, CA3, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MAOB, MMP2, MMP9, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TOP1 |
10.3018 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALPL, APP, AXL, CA2, CA3, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSPA1A, HTR5A, IGF1R, INSR, KDR, MAOB, MMP2, PPARA, PTGS2, RORC, SMAD3, SRC, TEK |
10.1074 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, CSNK2A1, CXCL8, CYP1B1, DRD2, DRD3, EGFR, ESRRA, F10, F2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
9.8484 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
9.74016 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, APP, CA2, CA9, CSNK2A1, CXCL8, CYP1A2, DRD1, EGFR, ESR1, ESRRA, FABP3, FLT3, HTR5A, IGF1R, INSR, MAOB, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
9.64979 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP1, XDH |
9.56454 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HSD17B1, MET, MIF, PPARA, PTGS1, PTGS2 |
9.41593 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AXL, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F2, F3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
8.89947 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP2, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP1, XDH |
8.86992 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDC25B, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F2, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTGS2, TEK |
8.86992 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FLT3, HTR5A, MAOB, PTGS2, RORC, SRC, TEK |
8.73275 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
8.25239 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGS1, PTGS2 |
8.18527 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA3, CA6, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, F10, F2, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MAOB, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP1 |
8.15299 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, APP, CDC25B, DRD1, DRD2, DRD3, DUSP3, EGFR, ESRRB, F2, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
8.13652 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, APP, CDC25B, DRD1, DRD2, DRD3, DUSP3, EGFR, ESRRB, F2, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
8.05877 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
8.04276 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESRRB, F10, F2, F3, FABP4, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TOP1 |
8.04276 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGS1, PTGS2 |
7.9443 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, APP, CDC25B, DRD1, DRD2, EGFR, ESRRB, F2, FABP3, FLT3, HTR2A, HTR2B, INSR, KDR, MIF, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.94182 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, APP, CDC25B, DRD1, DRD2, EGFR, ESRRB, F2, FABP3, FLT3, HTR2A, HTR2B, INSR, KDR, MIF, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.94182 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
7.8541 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HTR5A, INSR, MAOB, PPARA, PTGS2, SRC, TEK |
7.75834 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
7.71346 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CSNK2A1, CXCL8, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.68455 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, APP, AURKB, AXL, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.67838 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK |
7.5894 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
7.53474 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, APP, AXL, CA2, CXCL8, CYP1B1, DRD2, DRD3, EGFR, ESRRB, F2, F3, HCAR2, HSPA1A, HTR2A, HTR2B, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIM1, PTGS2, SMAD3, SRC, TEK |
7.29002 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, CXCL8, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
7.26582 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, APP, AURKB, CDC25B, CSNK2A1, CXCL8, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MET, MIF, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.25756 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, F2, HCAR2, HTR2A, HTR2B, KDR, MIF, PTGS2, SRC |
7.19983 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
7.09947 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, CA3, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, HTR2A, HTR2B, KDR, MAOB, PTGS2, SRC, TOP1 |
7.0445 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
7.01357 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
7.01357 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, F2, FABP3, FLT3, HCAR2, HTR2A, HTR2B, PPARA, PTGS2, RORC, SRC, TEK |
6.83047 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MIF, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
6.81908 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, KDR, MIF, PDE5A, PTPN1, SRC, TEK, XDH |
6.80969 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, CXCL8, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
6.7705 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD2, EGFR, FABP3, FABP4, FUT7, MET, MIF, PPARA, PTGS1, PTGS2 |
6.77046 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTGS2, PTPN1, SIGMAR1, SMAD3, SRC, TEK, XDH |
6.76903 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F2, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MIF, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.76852 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, CXCL8, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
6.76852 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTGS2, PTPN1, SIGMAR1, SMAD3, SRC, TEK, XDH |
6.76852 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, CXCL8, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.76795 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.76795 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.76795 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, APP, AURKB, CDC25B, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
6.76675 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, ESR1, HSD17B1 |
6.76561 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CXCL8, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F2, F3, FABP4, KDR, MET, MIF, MMP12, PPARA, PTGS2, SMAD3, TEK |
6.72073 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, HSPA1A, MAOB |
6.68953 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AURKB, AXL, CSNK2A1, CXCL8, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GPR35, HSPA1A, HTR2A, HTR2B, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
6.67624 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, APP, CDC25B, DRD2, EGFR, ESRRB, F2, FLT3, HTR2A, HTR2B, INSR, KDR, MIF, MMP9, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
6.64798 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, CXCL8, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.6164 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MAOB, MMP9, PTGS2, SRC |
6.56912 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGS1, PTGS2 |
6.53749 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK |
6.53648 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, DRD2, DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MIF, PDE5A, PTPN1, SRC, TEK, XDH |
6.52204 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HTR5A, MAOB, PTGS2, RORC, SRC |
6.49757 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, F2, HTR2A, HTR2B, KDR, SRC |
6.48794 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
6.48794 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, CXCL8, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.48794 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
6.43651 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3, FABP4, FLT3, GPR35, HTR2A, HTR2B, INSR, MET, SMAD3, SRC |
6.41017 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, EGFR, F2, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, INSR, MAOB, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC |
6.40233 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, CXCL8, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.37302 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AXL, CA1, CA2, CSNK2A1, CXCL8, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SMAD3, SRC, TEK |
6.37302 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, DUSP3, EGFR, HTR2A, HTR2B, KDR, MIF, PTPN1, SRC, TEK |
6.35729 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, CXCL8, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.31708 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MIF, MMP9, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
6.31708 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, EGFR, PTGS2 |
6.309 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3, FABP4, GPR35, HTR2A, HTR2B, INSR, MET, SMAD3 |
6.29115 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MIF, MMP9, PIM1, PTGS2, PTPN1, SIGMAR1, SMAD3, SRC, TEK, XDH |
6.28915 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, CDC25B, DRD2, EGFR, F2, FLT3, HTR2A, HTR2B, INSR, KDR, MIF, MMP9, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
6.28256 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FABP3, FLT3, HTR2A, HTR2B, PPARA, PTGS2, SRC, TEK |
6.25989 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.25055 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
6.23899 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
6.23899 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
6.22655 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.11795 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, FUT7, HTR2A, HTR2B, HTR5A, INSR, KDR, MAOB, MET, MIF, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SIGMAR1, SMAD3, SRC, TEK |
6.06993 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA, PTGS1, PTGS2 |
6.02868 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
6.01544 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
5.98979 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HTR2A, PTGS2 |
5.96297 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HTR2A, PTGS2 |
5.96297 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CA3, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PIM1, PTGS2, PTPN1, SRC, TEK, TOP1, XDH |
5.96297 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F2, F3, FABP4, HSPA1A, IGF1R, MET, MIF, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.88641 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CA2, CXCL8, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F2, F3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
5.82378 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AURKB, AXL, CSNK2A1, CXCL8, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
5.79573 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.75854 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.75854 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
5.75757 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2 |
5.73848 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, APP, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, KDR, MIF, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.72619 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.71354 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR1A, INSR, MAOB, PTGS2, SMAD3 |
5.70719 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AXL, CA2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, F2, FLT3, HTR5A, INSR, KDR, MAOB, MMP9, PIM1, PPARA, PTGS2, RORC, SIGMAR1, SMAD3, SRC, TEK |
5.70719 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, EGFR, HTR2A, HTR2B, KDR, MIF, SRC, TEK |
5.70269 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, F2, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
5.63269 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CA3, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PIM1, PTGS2, PTPN1, SRC, TEK, TOP1, XDH |
5.57627 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, MIF, PDE5A, PTPN1, SRC, TEK |
5.55354 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, APP, CDC25B, DRD2, EGFR, ESR1, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, KDR, MIF, MMP9, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.55018 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, APP, CA2, CXCL8, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, INSR, SIGMAR1, SRC |
5.55018 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HCAR2, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SIGMAR1, SMAD3, SRC, TEK, TOP1, XDH |
5.54256 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MIF, MMP9, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.51779 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, F2, HCAR2, HTR2B, INSR, MIF, MMP12, PTGS2, SMAD3, SRC |
5.48525 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3, GPR35, HTR2A, HTR2B, SMAD3 |
5.45418 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, MIF, PDE5A, PTPN1, SRC |
5.45268 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.45268 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC, TEK |
5.40157 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4, PTGS1, RORC |
5.34724 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HCAR2, HSD17B1, HTR1A, HTR2A |
5.3056 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F2, F3, FLT3, FUT7, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP1, XDH |
5.29829 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, HTR7, PPARA, RORC, SRC, TOP1 |
5.27903 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HSPA1A, HTR2A, HTR2B, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
5.23174 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
5.23174 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, F2, GPR35, HTR1A, HTR2A, MAOB, MIF, MMP9, PTGS2 |
5.1971 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, F2, HCAR2, PTGS2 |
5.19436 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AXL, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PTGS2, RORC, SMAD3, SRC |
5.16711 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, APP, AURKB, CDC25B, DRD2, EGFR, ESR1, ESR2, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, MET, MIF, MMP9, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
5.16556 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, DUSP3, EGFR, F2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, MIF, PDE5A, PTPN1, SRC, TEK |
5.16506 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.13558 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
4.96978 |
[BP] GO:0016477 |
cell migration
|
AXL, CXCL8, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MIF, MMP1, MMP12, MMP9, SRC, TEK |
4.95198 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, F2, FLT3, HTR2A, HTR2B, INSR, MIF, PDE5A, PTPN1, SRC, TEK |
4.95198 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A, MAOB |
4.95032 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
4.94764 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
4.93685 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
4.93277 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.88205 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, APP, AURKB, CDC25B, DRD2, EGFR, ESR1, F2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, MIF, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
4.88205 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, CA2, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, INSR, KDR, PPARA, SMAD3, SRC, TEK |
4.83939 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.82838 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MAOB, MMP1, MMP12, MMP2, MMP9, PDE5A, SRC, XDH |
4.79291 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.77804 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CA3, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, MAOB, SRC |
4.74358 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, APP, CDC25B, DRD2, EGFR, F2, FLT3, HTR2A, HTR2B, INSR, KDR, MIF, MMP9, PDE5A, PTGS2, PTPN1, SRC, TEK, XDH |
4.7218 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, DRD2, DRD3, GPR35, HTR2A, MAOB, MMP9, PTGS2 |
4.70687 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AXL, CXCL8, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, PTGS2, RORC, SMAD3, SRC |
4.6801 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR, HTR2A, PTGS2 |
4.64434 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, HTR2A, HTR2B, INSR, MIF, PDE5A, PTPN1, SRC |
4.63353 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, HTR1A, MAOB |
4.62142 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP1, XDH |
4.60699 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, EGFR, F2, FLT3, HTR2A, HTR2B, INSR, MIF, PDE5A, PTPN1, SRC, TEK |
4.60558 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, F2, FABP4, HSPA1A, MMP12, MMP2, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
4.59089 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, APP, DRD1, DRD2, DRD3, EGFR, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
4.58508 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.58232 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, MIF, PDE5A, PTPN1, SRC |
4.58232 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, HSD17B1, MAOB, PTGS1, PTGS2, XDH |
4.57683 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CA3, CYP1B1, EGFR, HSPA1A, MMP9, PTGS1, PTGS2, SRC |
4.5519 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, DRD2, DRD3, PPARA, PTGS1, PTGS2, SMAD3 |
4.5519 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
4.52123 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.49632 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, SRC, TEK |
4.49159 |
[BP] GO:0040011 |
locomotion
|
AXL, CXCL8, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MET, MIF, MMP1, MMP12, MMP9, SRC, TEK |
4.4729 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A, PTGS2 |
4.46637 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.46637 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, PTGS2, RORC, SRC |
4.46637 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, F2, MIF, PPARA, SMAD3, TEK |
4.45289 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CXCL8, EGFR, F2, F3, FABP4, KDR, MET, MIF, PTGS2, SMAD3 |
4.45289 |
[BP] GO:0048870 |
cell motility
|
AXL, CXCL8, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MIF, MMP1, MMP12, MMP9, SRC, TEK |
4.45289 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, DRD2, DRD3, EGFR, F2, HCAR2, HTR2B, MIF, MMP12, PTGS2, PTPN1, SMAD3, SRC |
4.44328 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
4.42296 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR, HTR6 |
4.41175 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, EGFR |
4.39794 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, HTR2A, INSR, MET, SMAD3, SRC |
4.38645 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
4.37414 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, APP, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F2, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.37363 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTGS2, RORC, SMAD3, SRC |
4.36471 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
4.35962 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, EGFR, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
4.3272 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, PTGS2 |
4.26821 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, MIF, SRC |
4.25842 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, CXCL8, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
4.25596 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC, TEK |
4.19477 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP1, XDH |
4.16382 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, APP, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
4.15411 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, F2, MMP12, PPARA, SMAD3, TEK |
4.15126 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CXCL8, CYP1B1, DRD1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, PTGS2, RORC, SRC |
4.14951 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR2B, MIF, MMP12, SRC |
4.14829 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, CXCL8, DRD1, DRD2, DRD3, EGFR, HTR2B, HTR5A, KDR |
4.13304 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK |
4.10635 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.08593 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
4.07442 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
4.07389 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP2, MMP9, NUAK1, PTGS2, PTPN1, RORC, SMAD3, SRC |
4.06556 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA, PTGS1, PTGS2 |
4.04498 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, APP, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
4.04498 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, DRD2, EGFR, F2, HCAR2, HTR2B, MIF, MMP12, PTGS2, SMAD3, SRC |
4.02781 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DRD2, EGFR, F2, PPARA, SMAD3 |
4.02564 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, HTR1A, MAOB |
4.02111 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOB |
4.01049 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOB |
4.01049 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, APP, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
4.0015 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, EGFR |
4.00015 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MAOB, MMP9, PTGS2 |
3.99433 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.97942 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR1A, HTR2A, HTR2B, MAOB, MIF, MMP12, SRC |
3.95816 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
3.93453 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.90743 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.89866 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.8986 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
3.88777 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HCAR2, HTR2B, MIF, MMP12, SRC |
3.8824 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, AXL, CXCL8, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MET, MIF, NUAK1, PTPN1, SRC, TEK |
3.87428 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, MIF, PDE5A, PTPN1, SRC |
3.85653 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.83998 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
3.83457 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
3.83457 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, HTR7, PPARA, RORC, TOP1 |
3.78162 |
[BP] GO:0007200 |
None
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B |
3.77658 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, MIF, PDE5A, PTPN1, SRC |
3.7686 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, DRD2, EGFR, F2, HCAR2, HTR2B, MIF, MMP12, PTGS2, SMAD3, SRC |
3.76142 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.7593 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK |
3.75032 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
3.73681 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, DRD2, DRD3, EGFR, GPR35, HCAR2, HTR2A, PDE5A, PTGS2, SMAD3 |
3.73284 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, PPARA |
3.72266 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, F2, INSR, PTGS2, SMAD3, XDH |
3.70333 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP1, XDH |
3.70333 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AXL, CA2, CXCL8, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F2, F3, HTR2A, INSR, KDR, MIF, NUAK1, PDE5A, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, XDH |
3.70333 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.68785 |
[BP] GO:0050890 |
None
|
ADORA1, APP, DRD1, DRD2, DRD3, EGFR, HTR2A, INSR, PTGS2 |
3.68135 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, FLT3, HTR2A, HTR2B, INSR, MIF, PDE5A, PTPN1, SRC |
3.66749 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.66467 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR1A, HTR2A, HTR2B, MAOB, MIF, MMP12, SRC |
3.63104 |
[BP] GO:0007202 |
None
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.61511 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.61511 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.58479 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA1A, APP, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F2, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PDE5A, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.58479 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MIF, MMP9, PTGS2, PTPN1, SRC |
3.58277 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F2, FABP4, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, XDH |
3.57272 |
[BP] GO:0050927 |
None
|
CXCL8, F3, KDR, SMAD3 |
3.54808 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, APP, DRD1, DRD2, DRD3, EGFR, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.53994 |
[BP] GO:0031623 |
None
|
ACHE, CXCL8, DRD2, DRD3, HTR2B |
3.53959 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC, TOP1 |
3.53959 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.53635 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, CA2, CA3, CA9, CXCL8, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, F2, HSPA1A, HTR1A, MIF, MMP2, MMP9, NUAK1, PPARA, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK |
3.521 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.51257 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.51257 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.51257 |
[BP] GO:0050926 |
None
|
CXCL8, F3, KDR, SMAD3 |
3.49112 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.48721 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
3.4755 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, INSR, MET, MMP12, PPARA, PTGS2, RORC, SMAD3, SRC |
3.45735 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.45735 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.45735 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.45735 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.45735 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, F10, F2, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TOP1 |
3.45042 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.41365 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
APP, AXL, CXCL8, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, HTR2B, HTR6, KDR, MIF, MMP1, MMP12, MMP9, PTGS2, SRC, TEK |
3.39564 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3, MAOB |
3.37647 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.36368 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.36188 |
[BP] GO:0051223 |
None
|
ACHE, APP, DRD2, DRD3, EGFR, F2, HCAR2, HTR2B, MIF, MMP12, PTGS2, PTPN1, SMAD3, SRC |
3.35944 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, CA2, CXCL8, CYP19A1, DRD2, DUSP3, ESR1, ESRRA, F2, HCAR2, HSPA1A, MIF, MMP12, MMP2, PDE5A, PTPN1, SMAD3, SRC |
3.35944 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, F2, FABP4, PPARA, PTGS2, SMAD3, TEK |
3.34011 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.32114 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, HTR2A, MIF, PTPN1, SRC |
3.31943 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.31174 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, CXCL8, DRD1, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, PTGS2, SMAD3, SRC |
3.31174 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, APP, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
3.2933 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR2A, INSR, PDE5A, PPARA |
3.28489 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.27995 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR, MAOB |
3.27644 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, EGFR, HCAR2, HTR2B, MIF, MMP12, SRC |
3.27644 |
[BP] GO:0007611 |
None
|
APP, DRD1, DRD2, DRD3, EGFR, HTR2A, INSR, PTGS2 |
3.27644 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, F2, INSR, PTGS2, SMAD3, XDH |
3.25118 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA1A, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.2466 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.23701 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, CDC25B, CSNK2A1, CXCL8, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, MIF, PIM1, PTGS2, SMAD3, SRC |
3.2297 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.22874 |
[BP] GO:0045744 |
None
|
CXCL8, DRD2, DRD3, MET |
3.22874 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR2A, INSR, PDE5A, PPARA |
3.20907 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, APP, CXCL8, CYP1B1, DRD2, FABP3, HSPA1A, PDE5A, PTGS2, SMAD3, XDH |
3.19991 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2D6, CYP3A4, MAOB |
3.19991 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, CXCL8, DRD2, EGFR, F2, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.18438 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, F2, PPARA, SMAD3, TEK |
3.18072 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.18072 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, HTR2A, IGF1R, INSR, MET, MMP12, PPARA, PTPN1, RORC, SMAD3, SRC |
3.1806 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, INSR, PPARA, SRC |
3.1566 |
[BP] GO:0070201 |
None
|
ACHE, APP, DRD2, DRD3, EGFR, F2, HCAR2, HTR2B, MIF, MMP12, PTGS2, PTPN1, SMAD3, SRC |
3.1426 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
ADRA1A, APP, CSNK2A1, DRD2, EGFR, ESR1, F3, HSPA1A, HTR2A, HTR2B, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, XDH |
3.13976 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
F2, FLT3, SRC, TEK |
3.13441 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.13441 |
[BP] GO:0045907 |
None
|
ADRA1A, EGFR, HTR2A, PTGS2 |
3.13441 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, F2, GPR35, HTR2A, HTR2B |
3.13441 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SIGMAR1, SMAD3, SRC, TEK, TOP1, XDH |
3.12959 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.12959 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.12538 |
[BP] GO:0050920 |
regulation of chemotaxis
|
CXCL8, CYP19A1, F3, KDR, MET, MIF, SMAD3 |
3.07426 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, HTR5A, PTGS2 |
3.01127 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
3.00878 |
[BP] GO:0070989 |
oxidative demethylation
|
CYP1A2, CYP2D6, CYP3A4 |
3.00878 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.99603 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.9737 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, PDE5A |
2.95812 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.95529 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX5, MIF, PTGS1, PTGS2 |
2.95529 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
2.95112 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
2.95112 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
2.93732 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SIGMAR1, SMAD3, SRC, TEK, XDH |
2.93732 |
[BP] GO:0007610 |
None
|
APP, DRD1, DRD2, DRD3, EGFR, HTR1A, HTR2A, HTR2B, INSR, PPARA, PTGS2 |
2.92083 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.92083 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, F2, PTGS2, SMAD3, SRC |
2.92083 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.92083 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.92083 |
[BP] GO:0001516 |
None
|
MIF, PTGS1, PTGS2 |
2.92083 |
[BP] GO:0046457 |
None
|
MIF, PTGS1, PTGS2 |
2.92083 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.90473 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, APP, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR1A, HTR2A, HTR2B, HTR7, INSR, PDE5A, PTGS2, SRC, TEK |
2.89114 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, EGFR, HCAR2, HTR2B, MIF, MMP12, SRC |
2.8836 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, EGFR, ESR1, FLT3, HTR1A, MET, MIF, PIM1, SRC, TEK |
2.86488 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, DRD3, EGFR, HCAR2, HTR2B, MIF, MMP12, SRC |
2.8511 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AXL, CA2, CXCL8, CYP1B1, DRD2, ESRRB, F3, HTR2A, INSR, KDR, PDE5A, PIM1, PTGS2, SMAD3, SRC, TEK |
2.8499 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP2A6, CYP3A4, HSPA1A, MAOB, PDE5A, XDH |
2.83692 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CXCL8, CYP1A1, CYP1A2, MAOB, PTGS2, SRC |
2.83389 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.83033 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.83033 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.83033 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, DRD3, INSR, PTGS2 |
2.82583 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SIGMAR1, SMAD3, SRC, TEK, TOP1, XDH |
2.81844 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.80678 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.80678 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP1, XDH |
2.80093 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MAOB, PDE5A, XDH |
2.79177 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, PTGS2, SRC |
2.7901 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
2.78165 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.78165 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.77634 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.77302 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, HTR2A, PPARA |
2.76838 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, DRD2, EGFR, HTR2A, PDE5A, PTGS2 |
2.76464 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, ESR1, F2, GPR35, HTR2A, HTR2B, SMAD3 |
2.76384 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, CSNK2A1, DRD2, DRD3, EGFR, F2, HCAR2, HTR2B, MIF, MMP12, PTGS2, PTPN1, SMAD3, SRC |
2.76171 |
[BP] GO:0060191 |
regulation of lipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
2.75862 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.75542 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB, HTR2B |
2.72372 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.71642 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR |
2.70975 |
[BP] GO:0032845 |
None
|
ADORA1, DRD2, HTR2A, HTR2B, MIF, SRC |
2.70975 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
2.69995 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, ESR2, ESRRA, F2, FABP4, HSPA1A, HTR2B, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, XDH |
2.68565 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.67657 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.67657 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.67424 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CXCL8, CYP1A1, CYP1A2, MAOB, PTGS2, SRC |
2.66518 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, HTR1A, MAOB |
2.65297 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.65297 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CXCL8, DRD1, DRD2, DRD3, EGFR, F10, F2, FABP3, HSPA1A, HTR2A, HTR2B, MIF, MMP12, MMP9, PPARA, SIGMAR1, SRC, XDH |
2.65258 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, CA2, EGFR, FLT3, MAOB, PTGS2, SRC |
2.63761 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.63465 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, EGFR, IGF1R, INSR, MMP2, PTGS2, SRC |
2.58121 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
CYP1B1, DRD2, HSPA1A, HTR2B, MIF, MMP12, PTGS2, SMAD3, SRC |
2.58121 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CXCL8, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F2, FABP3, HSPA1A, HTR2A, HTR2B, MIF, MMP12, MMP9, PPARA, SIGMAR1, SRC, XDH |
2.57824 |
[BP] GO:0009822 |
alkaloid catabolic process
|
CYP2D6, CYP3A4 |
2.57499 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.57499 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.57499 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.57499 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.57499 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CXCL8, CYP1B1, F3, KDR, PTGS2, TEK |
2.5701 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, APP, DRD2, DRD3, GPR35, HSPA1A, HTR2A, MAOB, MMP9, PTGS2 |
2.56621 |
[BP] GO:0043112 |
None
|
ACHE, CXCL8, DRD2, DRD3, HTR2B |
2.55729 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, EGFR, FLT3, MAOB, PTGS2, SRC |
2.55729 |
[BP] GO:0045821 |
None
|
ESRRB, HTR2A, INSR |
2.53852 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.53852 |
[BP] GO:0010906 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.53852 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, CXCL8, EGFR, F2, FLT3, FUT7, HSPA1A, MIF, MMP9, RORC, SMAD3, SRC |
2.52403 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, F2, FLT3, KDR, TEK |
2.5198 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MIF, MMP9, PTGS2, PTPN1, SRC |
2.51754 |
[BP] GO:0042307 |
positive regulation of protein import into nucleus
|
APP, EGFR, F2, PTGS2, SMAD3 |
2.50131 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
2.50131 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ADRA1A, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CXCL8, DRD1, DRD2, DRD3, F10, F2, FABP3, HSPA1A, HTR2A, HTR2B, MIF, MMP12, MMP9, PPARA, SIGMAR1, SRC, XDH |
2.49476 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.49184 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.47752 |
[BP] GO:0042069 |
None
|
DRD1, HTR1A, MAOB |
2.47752 |
[BP] GO:0042053 |
None
|
DRD1, HTR1A, MAOB |
2.47752 |
[BP] GO:0051197 |
None
|
ESRRB, HTR2A, INSR |
2.47752 |
[BP] GO:0001817 |
regulation of cytokine production
|
AXL, CYP1B1, DRD2, F2, HSPA1A, HTR2B, MIF, MMP12, PTGS2, SMAD3, SRC |
2.4701 |
[BP] GO:1904591 |
positive regulation of protein import
|
APP, EGFR, F2, PTGS2, SMAD3 |
2.46922 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.46922 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, XDH |
2.46922 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.46664 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, IGF1R, INSR, KDR, MET, MMP12, PPARA, RORC, SMAD3, SRC |
2.46396 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.46396 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.46396 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
F2, FLT3, SRC, TEK |
2.46396 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR, MAOB |
2.43395 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.4331 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2 |
2.43057 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.42173 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.4064 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.4064 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FABP4, HSPA1A, MAOB, PDE5A, SRC, XDH |
2.39989 |
[BP] GO:0050708 |
None
|
ACHE, DRD2, DRD3, EGFR, HCAR2, HTR2B, MIF, MMP12, SRC |
2.38795 |
[BP] GO:0050678 |
None
|
EGFR, F3, HTR2B, KDR, MMP12, SMAD3, TEK, XDH |
2.38564 |
[BP] GO:0007613 |
None
|
DRD1, DRD2, HTR2A, INSR, PTGS2 |
2.38385 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, CXCL8, EGFR, INSR, KDR, SMAD3, SRC |
2.38005 |
[BP] GO:0044419 |
interspecies interaction between organisms
|
AXL, EGFR, F2, HSPA1A, HTR2A, INSR, KDR, MET, MMP1, SMAD3, SRC, TOP1 |
2.36965 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.36659 |
[BP] GO:0051968 |
None
|
DRD1, EGFR, PTGS2 |
2.36659 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.36659 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, EGFR, IGF1R, INSR, MMP2, PTGS2, SRC |
2.36479 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.34941 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, HTR2A, MIF, PTPN1, SRC |
2.33643 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.33164 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.33164 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, HTR2A, INSR, PPARA, RORC, SRC |
2.33164 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.33164 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.33164 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.33164 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.33164 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HSPA1A, IGF1R, MET, MIF, NUAK1, PTGS2, PTPN1, XDH |
2.3228 |
[BP] GO:0050679 |
None
|
EGFR, F3, HTR2B, KDR, MMP12, TEK |
2.3228 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CXCL8, CYP1B1, F3, KDR, PTGS2, TEK |
2.3228 |
[BP] GO:0051194 |
None
|
ESRRB, HTR2A, INSR |
2.3228 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.3228 |
[BP] GO:0051172 |
None
|
APP, AURKB, CSNK2A1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F2, FABP4, HSPA1A, IGF1R, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, XDH |
2.30495 |
[BP] GO:0040008 |
regulation of growth
|
APP, CSNK2A1, DRD2, DRD3, EGFR, ESR2, F2, HSPA1A, INSR, PIM1, SMAD3 |
2.30176 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, CYP2D6, MET, MMP9, PPARA, SMAD3, SRC |
2.29679 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, MAOB, SRC |
2.28678 |
[BP] GO:0070988 |
demethylation
|
CYP1A1, CYP1A2, CYP2D6, CYP3A4 |
2.28678 |
[BP] GO:0050715 |
None
|
DRD2, HTR2B, MIF, MMP12, SRC |
2.28 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3 |
2.27104 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.27082 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27082 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, F2, HTR2A, HTR2B |
2.26506 |
[BP] GO:0019229 |
None
|
ADRA1A, EGFR, HTR2A, PTGS2 |
2.26312 |
[BP] GO:0001503 |
ossification
|
ALPL, EGFR, MMP2, MMP9, TEK |
2.24867 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD17B1, MIF, PTGS1, PTGS2 |
2.24629 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1 |
2.23776 |
[BP] GO:0050900 |
leukocyte migration
|
CXCL8, F2, FUT7, MIF, MMP1, MMP9, SRC, TEK |
2.23776 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, EGFR, HCAR2, HTR2B, MET, PPARA, SMAD3 |
2.22578 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CYP19A1, DRD2, EGFR, HCAR2, HTR1A, HTR2A |
2.22578 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.22222 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.22222 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AXL, CA2, CXCL8, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F2, F3, INSR, KDR, PIM1, PTGS2, SMAD3, SRC, TEK, XDH |
2.22202 |
[BP] GO:0010959 |
None
|
ADORA1, DRD1, DRD2, DRD3, F2, GPR35, HTR2A, PTGS2 |
2.20885 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, CDC25B, CYP1A1, DRD1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, HTR2B, KDR, MET, MIF, MMP2, MMP9, PTGS2, RORC, SMAD3, SRC, TEK |
2.20535 |
[BP] GO:0045932 |
None
|
ADORA1, PDE5A, PTGS2 |
2.17438 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, PTGS2 |
2.16821 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.16821 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.14854 |
[BP] GO:0010675 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.14854 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.14854 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.14854 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.14854 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.14854 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.14854 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.14854 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.14854 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, INSR |
2.13941 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.13941 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.13941 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.13941 |
[BP] GO:0006693 |
None
|
MIF, PTGS1, PTGS2 |
2.13941 |
[BP] GO:0006692 |
None
|
MIF, PTGS1, PTGS2 |
2.13941 |
[BP] GO:0045822 |
None
|
ADORA1, ADRA1A, PDE5A |
2.13941 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
F2, FLT3, KDR, TEK |
2.13244 |
[BP] GO:0006110 |
None
|
ESRRB, HTR2A, INSR, PPARA |
2.10864 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.10864 |
[BP] GO:0070848 |
response to growth factor
|
APP, CXCL8, EGFR, INSR, KDR, SMAD3, SRC |
2.09773 |
[BP] GO:0045745 |
None
|
DRD2, DRD3, F2 |
2.09487 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.08748 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, INSR, MMP2, MMP9, PTGS2, SRC |
2.08298 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2 |
2.08083 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.07385 |
[BP] GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway
|
CXCL8, DRD2, DRD3, F2, MET |
2.05367 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
2.05367 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.05367 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.05367 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, PTGS2 |
2.04955 |
[BP] GO:1903524 |
None
|
ADRA1A, EGFR, HTR2A, PTGS2 |
2.04696 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.04696 |
[BP] GO:0050921 |
positive regulation of chemotaxis
|
CXCL8, F3, KDR, MET, SMAD3 |
2.04146 |
[BP] GO:1904062 |
None
|
APP, DRD1, DRD2, DRD3, F2, GPR35, MMP9 |
2.034 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3 |
2.02612 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2 |
2.01556 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
MIF, PTGS1, PTGS2 |
2.01488 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, INSR, PTGS2, SRC |
2.01032 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.01032 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC |
2.01032 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3 |
2.01032 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, F2, F3, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TOP1 |
2.01032 |
[BP] GO:0051241 |
negative regulation of multicellular organismal process
|
ADORA1, ADRA1A, APP, AXL, DRD2, DRD3, EGFR, F2, GPR35, PDE5A, PTGS2, SMAD3, TEK, XDH |
2.01032 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.01032 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.01032 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.01032 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.01032 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.01032 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.01032 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.01032 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR, MIF |
2.00806 |
[BP] GO:0051704 |
multi-organism process
|
APP, AXL, CYP1A1, DRD3, EGFR, F2, HSPA1A, HTR2A, INSR, KDR, MET, MMP1, MMP12, SMAD3, SRC, TOP1 |
2.00459 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CA4, DRD1, DRD2, DRD3, F10, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
6.46782 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CA2, CA4, CA9, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F2, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTGS2, SIGMAR1, SRC, TEK |
5.44493 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, AXL, DRD1, DRD2, DRD3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
4.95198 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPN1, SMAD3, SRC, TEK |
4.25842 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F2, F3, FLT3, FUT7, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MAOB, MET, PTGS1, PTGS2, PTPN1, SIGMAR1, SRC, TEK |
3.50417 |
[CC] GO:0045121 |
membrane raft
|
ADRA1A, APP, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK |
3.45735 |
[CC] GO:0098857 |
membrane microdomain
|
ADRA1A, APP, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK |
3.43838 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, EGFR, F10, F2, FLT3, PTGS1, PTGS2, PTPN1, SIGMAR1 |
3.24797 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX5, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ESR1, F10, F2, F3, FLT3, FUT7, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MAOB, MET, MMP2, PIM1, PTGS1, PTGS2, PTPN1, SIGMAR1, SMAD3, SRC, TEK |
3.21471 |
[CC] GO:0005901 |
caveola
|
ADRA1A, HTR2A, INSR, PTGS2, SRC |
3.0763 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, DRD1, DRD2, EGFR, HTR2A, INSR, MET, PTGS2, SIGMAR1, SRC, TEK |
2.96544 |
[CC] GO:0098589 |
membrane region
|
ADRA1A, APP, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK |
2.90066 |
[CC] GO:0044853 |
plasma membrane raft
|
ADRA1A, HTR2A, INSR, PTGS2, SRC |
2.63465 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALPL, AOX1, APP, AURKB, AXL, CA1, CA2, CA4, CA5A, CA5B, CA6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, HSPA1A, HTR2A, HTR5A, IGF1R, INSR, KDR, MAOB, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SIGMAR1, SMAD3, SRC, TOP1, XDH |
2.49684 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.42173 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AURKB, CA1, CA2, CA3, CA4, CA5A, CA5B, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, HTR2A, HTR5A, INSR, KDR, MAOB, MIF, MMP2, MMP9, PDE5A, PIM1, PTGS1, PTGS2, PTPN1, SIGMAR1, SMAD3, SRC, TOP1, XDH |
2.35402 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.19721 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, EGFR, PTGS1, PTGS2, SIGMAR1 |
2.1914 |
[CC] GO:0005783 |
None
|
ADORA1, APP, CA4, CYP19A1, CYP2D6, FLT3, HSPA1A, HTR5A, KDR, PTGS2, PTPN1, SIGMAR1, XDH |
2.10694 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.01032 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
18.8067 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP1, XDH |
17.754 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, XDH |
17.754 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F2, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, XDH |
12.0033 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.9243 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, SIGMAR1, TEK |
11.1112 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.6211 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, SIGMAR1, TEK |
9.95241 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DUSP3, EGFR, F10, F2, F3, FLT3, FUT7, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PTGS1, PTGS2, PTPN1, SRC, TEK, TOP1, XDH |
9.95241 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4 |
9.95241 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, SIGMAR1, SMAD3, TEK |
9.69367 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, SIGMAR1, TEK |
9.66837 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3 |
8.73275 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4 |
8.53043 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, PTGS1, PTGS2, SRC |
8.32834 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SIGMAR1, SRC, TEK, TOP1 |
8.18527 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, PTGS1, PTGS2, SRC |
8.04276 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.94182 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, XDH |
7.45473 |
[MF] GO:0008227 |
None
|
ADRA1A, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.35266 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.08945 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F2, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, XDH |
6.95212 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
6.95212 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
6.95212 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
6.8928 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.7705 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.7705 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.76795 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.76795 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4 |
6.68761 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.62678 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, PTGS1, PTGS2 |
6.53749 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.44074 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, HSD17B1, MAOB, PTGS1, PTGS2, SRC, XDH |
6.37012 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6, CYP3A4 |
5.96297 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4 |
5.89449 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, HSD17B1, MAOB, PTGS1, PTGS2, XDH |
5.71842 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
5.70269 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.08521 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.08521 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.95905 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC |
4.95661 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
4.94764 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.64434 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, INSR, KDR, MAOB, MET, MMP12, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP1, XDH |
4.17793 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
4.14704 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC |
4.06315 |
[MF] GO:0008289 |
lipid binding
|
AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, HSD17B1, PPARA, RORC |
3.99838 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC |
3.91069 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, DRD1, DRD2, DRD3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
3.48144 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.36368 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.36368 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
3.34907 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, XDH |
3.31174 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, INSR, KDR, MAOB, MET, MMP12, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP1, XDH |
3.24659 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.00878 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
2.9737 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.9737 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.9737 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.9737 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.92083 |
[MF] GO:0005102 |
receptor binding
|
ADORA1, APP, CXCL8, DRD2, DRD3, EGFR, ESR1, ESR2, F2, FLT3, HSPA1A, HTR1A, IGF1R, INSR, KDR, MIF, PTPN1, SMAD3, SRC |
2.82133 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F2, F3, MMP1, MMP12, MMP2, MMP9 |
2.78165 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
2.75862 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.70422 |
[MF] GO:0005488 |
binding
|
ACHE, ADORA1, ADRA1A, AKR1B10, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F2, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SIGMAR1, SMAD3, SRC, TEK, TOP1, XDH |
2.68623 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.57499 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F10, F2, F3, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK, TOP1 |
2.53307 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.42173 |
[MF] GO:0043168 |
anion binding
|
AOX1, APP, AURKB, AXL, CSNK2A1, EGFR, F10, F2, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PIM1, SRC, TEK, TOP1, XDH |
2.36659 |
[MF] GO:0004252 |
None
|
F10, F2, F3, MMP1, MMP12, MMP2, MMP9 |
2.35402 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.33164 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.33164 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.33164 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.33164 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP1 |
2.32897 |
[MF] GO:0019899 |
enzyme binding
|
APP, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HSPA1A, MET, MIF, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
2.19517 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.19167 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.14854 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.14854 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.14854 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, CSNK2A1, DRD2, EGFR, ESR1, ESR2, FLT3, IGF1R, KDR, MAOB, MET, MIF, MMP9, PTGS2, SMAD3, XDH |
2.14762 |
[MF] GO:0008236 |
None
|
F10, F2, F3, MMP1, MMP12, MMP2, MMP9 |
2.10651 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PIM1, SRC, TEK, TOP1, XDH |
2.08172 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.02735 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.01488 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.01032 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.01032 |